Nattokinase Market

Nattokinase Market Study by 2,000 to 5,000 FU, 5,000 to 10,000 FU, 10,000 to 15,000 FU, and 15,000 to 20,000 FU Purity in Stabilizers, Antithrombotic Agents, and Others from 2023 to 2033

Analysis of Nattokinase Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Nattokinase Market Outlook (2023 to 2033)

Worldwide sales of nattokinase are estimated at US$ 35.57 million in 2023 and are forecasted to climb to US$ 47.35 million by 2033-end. The global nattokinase market is predicted to exhibit expansion at 2.9% CAGR over the next ten years.

Nattokinase is an enzyme that is obtained from a Japanese food called Natt?, which is made by fermentation of boiled soybeans by adding the bacterium Bacillus natto. Nattokinase has a cheese-like flavour and numerous health benefits that are anticipated to propel its demand over the coming years.

Increasing investments in research and development programs to know more about the benefits of natto and nattokinase, increasing consumption of plant-based dietary supplements, the rising popularity of plant-based foods and veganism, and heightened focus on fitness are some key aspects that could influence the consumption of nattokinase going forward.

  • In May 2023, a study by a research team at Osaka Metropolitan University’s Graduate School of Human Life and Ecology revealed that eating natto might help people to distress and possibly improve lifespan extendibility.

High prevalence of lifestyle disorders and chronic diseases coupled with the rapidly increasing aging population on a global scale is slated to set the stage for nattokinase companies to expand their business lucratively. Several benefits associated with the use of nattokinase tablets to treat various diseases are also anticipated to offer rewarding business scope across the forecast period.

New plant-based product companies are focusing on incorporating nattokinase in their products to meet the evolving demand from their consumers. An innovative approach towards using nattokinase powder and nattokinase tablets in different products to give them a unique taste and nutritional profile could open up new moneymaking opportunities for nattokinase suppliers as well as other companies involved.

  • In 2020, Zoh Probiotics, a manufacturer of probiotic products based in India, revealed its plans of adding natto to its DIY product range, which it did later in 2020. The company is well known for its kombucha and other fermented products that promote gut health.

On the flip side, the absence of research data for the long-term effects of nattokinase consumption and the lack of credible information regarding nattokinase could potentially take a chunk out of the global nattokinase market share over the next ten years.

A detailed account of industry-altering aspects such as new developments, product standards, local supply, pricing trends, and safety regulations have been mentioned in this latest nattokinase market study by Fact.MR.

Report Attributes Details

Nattokinase Market Size (2023)

US$ 35.57 Million

Projected Market Value (2033F)

US$ 47.35 Million

Global Market Growth Rate (2023 to 2033)

2.9% CAGR

Market Value of United States (2033F)

US$ 11.93 Million

Germany Market Growth Rate (2023 to 2033)

3.7% CAGR

Japan Market Value (2033F)

US$ 5.96 Million

China Market Value (2023)

US$ 4.73 Million

Historical Global Market Growth Rate (2018 to 2022)


Key Companies Profiled

  • NutraCap Labs
  • Infinita Biotech Private Limited
  • Xi'an Herb Bio-Tech Co. Ltd.
  • GeneFerm Biotechnology Co. Ltd.
  • Contek Life Science Co. Ltd.
  • Japan Bio Science Laboratory
  • Sungen Bioscience Co. Ltd.
  • Belle Chemical
  • Hexon Laboratories Private Limited

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Trend Will Influentially Determine the Future of Nattokinase Sales?

“Surging Popularity of Plant-based Supplements”

The globally popular trend of veganism has had a huge impact on different aspects of life and this trend is projected to play a crucial role in shaping the natto industry size in the future. Growing awareness regarding the ill effects of synthetic ingredients and changing consumer preferences are anticipated to promote sales of plant-based supplements and plant-based food products over the next ten years.

New nattokinase companies could focus on making products that are completely plant-based to satisfy evolving consumer demands and grow their business in a lucrative way.

More detailed insights on how new companies and established companies can benefit from the plant-based trend have been mentioned in this latest nattokinase research survey by the skilled analysts at Fact.MR, a market research and competitive intelligence provider.

Nattokinase Market  Size, Share, Trends, Growth, Demand and Sales Forecast Report by Fact.MR

Country-wise Insights

How Does This Research Define the United States Market?

“Surging Prevalence of Cardiovascular Disorders and Diabetes – Prime Growth Initiator”

Obesity has become a widespread issue in the United States in recent years and this has resulted in a notable increase in the number of people suffering from cardiac disorders. The adoption of a sedentary lifestyle coupled with poor eating habits is also anticipated to benefit the growth of the nattokinase market in the country over the next ten years.

  • Heart disease is the leading cause of death in the United States and around 695,000 people suffered loss of life due to the same in the year 2021. These statistics are provided by the Centers for Disease Control and Prevention (CDC).

Rising prevalence of diabetes, high awareness regarding fitness, expanding hypertensive population, and growing demand for functional foods and superfoods are other factors that are projected to uplift consumption of nattokinase across the forecast period in the country.

  • Sales of nattokinase in the United States are forecasted to rake in a value of US$ 11.93 million by 2033-end and are estimated to rise at a modest 3.2% CAGR over the next ten years.

Are European Country Investment-worthy Markets for Nattokinase Suppliers?

“High Preference for Plant-based Ingredients and Increasing Health Awareness Offering Lucrative Business Scope”

Preference for plant-based and vegan foods has increased exponentially in recent years in most European countries, which is projected to decidedly augment nattokinase demand over the coming years. The presence of key food manufacturers and their efforts to incorporate natural ingredients in their products is also a major trend that makes European countries highly remunerative spaces in the future.

Expanding geriatric population, high prevalence of chronic diseases and lifestyle disorders, supportive government initiatives, and growing focus on health are other prospects that could bolster nattokinase product sales over the next ten years.

  • Sales of nattokinase in the United Kingdom are predicted to increase at 3.5% CAGR over the next ten years to attain a value of US$ 3.55 million by the end of 2033.

Which Countries are Remunerative Spaces in the APAC Region?

“Japan and China to Offer Rewarding Business Opportunities”

Natto is a soy-based traditional dish of Japan and is the primary source for nattokinase extraction. The high popularity of natto as a cheap and nutritious breakfast in Japan has made people accustomed to the taste of nattokinase. The increasing senescent population and growing demand for plant-based natural dietary supplements are also predicted to uplift shipments of nattokinase over the next ten years.

  • Demand for nattokinase in Japan is predicted to increase at 3.6% CAGR over the next ten years and accumulate a revenue of US$ 5.96 million by 2033-end.
  • In March 2023, The Japan natto cooperative society federation announced the launch of its new website’s Chinese version. The initiative is part of the federation’s effort to promulgate the popularity of Natto to the world as it has supported the health of Japanese people immensely. China could witness a notable hike in the popularity of natto and nattokinase-based products following this development.

China and Japan have been closely influencing each other’s culture and food, which is a key prospect that is estimated to push nattokinase companies to invest in the Chinese marketplace. The growing popularity of plant-based food trends and evolving consumer preferences in China are predicted to create an opportune scenario for nattokinase vendors going forward.

  • Nattokinase sales in China are extrapolated to secure a revenue valuation of US$ 6.67 million by the end of the forecast period.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Category-wise Insights

Nattokinase of Which Purity Accounts for a Dominant Market Share?

"2,000 to 5,000 FU Purity Nattokinase to Maintain Hegemony"

Based on purity FU (Fibrin Units), the nattokinase market is segmented into 2,000 to 5,000 FU, 5,000 to 10,000 FU, 10,000 to 15,000 FU, and 15,000 to 20,000 FU.

Nattokinase with 2,000 to 5,000 FU purity is projected to account for a prominent share in the global marketplace throughout the forecast period. The recommended safe dosage of nattokinase is found to be 100 to 200 mg per day, which is the equivalent of 2,000 to 5,000 FU and hence contributes to the high share of this segment in the global industry landscape.

  • Shipments of nattokinase with 2,000 to 5,000 FU purity are projected to rise at 3.2% CAGR through 2033.

Where is Nattokinase Being Used Extensively?

“Pharmaceutical Formulations to Lead Revenue Generation”

Based on application, the nattokinase market is segmented into pharmaceutical formulations and nutraceutical formulations.

Use of natural ingredients in pharmaceutical formulations is increasing at a rapid pace owing to surging demand for pharmaceuticals around the world. Increasing awareness regarding the medical and health benefits associated with the consumption of nattokinase is also favoring its use in the pharmaceutical industry.

  • Use of nattokinase in pharmaceutical formulations is estimated to rise at 3.6% CAGR over the next ten years.

Competitive Landscape

Key producers of nattokinase are focusing on research and development of novel products to enhance their revenue generation capacity on a global level.

  • Sungen Bioscience Co. Ltd., a leading name in the global nattokinase industry signed an agreement with Shenyang Pharmaceutical University in July 2020 to develop a new form of biologic nattokinase injection and oral preparation.

A comprehensive and exhaustive analysis of all key market developments has been exclusively mentioned and discussed in this latest nattokinase research report by skilled analysts at Fact.MR.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Key Segments of Nattokinase Industry Research

  • By Purity FU (Fibrin Units) :

    • 2,000 to 5,000 FU
    • 5,000 to 10,000 FU
    • 10,000 to 15,000 FU
    • 15,000 to 20,000 FU
  • By Function :

    • Stabilizers
    • Antithrombotic Agents
    • Anti-Inflammatory Agents
    • Blood Pressure Regulators
    • Inhibitors
  • By Application :

    • Nutraceuticals (Formulations)
    • Pharmaceutical (Formulations)
  • By Region :

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

- FAQs -

What is the current nattokinase market value?

The global nattokinase market accounts for a valuation of US$ 35.57 million in 2023.

How big will the nattokinase market be by 2033?

Demand for nattokinase is set to rake in a revenue of US$ 47.35 million by the end of 2033.

At what pace will the market develop going forward?

Shipments of nattokinase are predicted to increase at 2.9% CAGR over the next ten years.

What are the factors driving the nattokinase market?

Changing lifestyles, high prevalence of cardiovascular disorders, rising consumer awareness, and high demand for plant-based products are key market drivers.

What statistics are listed in this research for the market in the United States?

Nattokinase sales in the United States are projected to reach US$ 98.66 million by 2033, rising at 3.2% CAGR from 2023 to 2033.

Who are the leading manufacturers of nattokinase?

Contek Life Science Co. Ltd., Japan Bio Science Laboratory, Sungen Bioscience Co. Ltd., and Belle Chemical are prime nattokinase manufacturers.

Nattokinase Market

Schedule a Call